Meeting
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
Authors
Habte Aragaw Yimer
The U.S. Oncology Network, Tyler, TX
Habte Aragaw Yimer , Wai Hong Wilson Tang , Mohan K. Tummala , Spencer Shao , Gina G. Chung , Fergus Couch , Jingjing Gao , Oliver Venn , Kathryn Kurtzman , Charles Swanton , Jessica M. Clement
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
New Targets and New Technologies (non-IO)
Clinical Trial Registration Number
NCT02889978
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3072)
DOI
10.1200/JCO.2021.39.15_suppl.3072
Abstract #
3072
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Performance of a targeted methylation-based multi-cancer early detection test by race/ethnicity.
First Author: Wai Hong Wilson Tang
Poster
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
First Author: Allen Lee Cohn
Poster
2024 ASCO Genitourinary Cancers Symposium
Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.
First Author: Amy K Taylor
Poster
2023 ASCO Annual Meeting
Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.
First Author: Giuseppe Di Caro